New Blueprint Website Launched!

Published on May 30, 2013

Blueprint Genetics is a new genetic diagnostics company that is based in Helsinki, Finland. The company started its operations in 2012 by setting up a laboratory for applying a targeted sequencing method called Oligonucleotide-Selective Sequencing (OS-Seq™)* for rare diseases diagnostics.

We are now launching first ten products, all of which serve cardiovascular disease diagnostics. Concurrently with the products we are launching a new website as we have been fairly under the radar so far. We believe that targeted sequencing is finding its way to the everyday life of clinicians and we’ll be working hard to make this happen!

Please stay tuned for further announcements and information about us. We will be making a more official product launch providing further information on our products. We will update our blog by posting relevant commenting about genetic testing, cardio-related disorders, NGS, or interesting genetic news in general. We can also be found on Twitter, under our company’s name, Blueprint Genetics, hope you follow us.

Best wishes,

The Blueprint Genetics Team

 

 

*(Myllykangas et al. 2011, PubMed:22020387)

Last modified: 05.30.2013

News

A Finnish study finds evidence indicating the JPH2 gene to be causative in hypertrophic cardiomyopathy

Published on September 21, 2018

This study1 provides the first substantial evidence of the JPH2 gene associating with monogenic familial hypertrophic cardiomyopathy (HCM). The study ‘Heterozygous Junctophilin-2 (JPH2) p.(Thr161Lys) is a monogenic cause for HCM with heart failure’ was published recently in PLOS ONE. Hypertrophic cardiomyopathy is considered the most common form of inherited cardiomyopathies,…

Read more

Subscribe to our newsletter